Brain fluorodeoxyglucose (FDG) PET in dementia
Takashi Kato(National Center for Geriatrics and Gerontology), Kengo Ito(National Center for Geriatrics and Gerontology), Akinori Nakamura(National Center for Geriatrics and Gerontology), Yoshitaka Inui(National Center for Geriatrics and Gerontology)
Cited by 235
Related Papers
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
|Nature|2018|1.7k
Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET
|NeuroImage|2002|839
A Randomized Controlled Trial of Multicomponent Exercise in Older Adults with Mild Cognitive Impairment
|PLoS ONE|2013|388
Somatosensory Homunculus as Drawn by MEG
|NeuroImage|1998|342